Cargando…

Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia

Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by enhanced platelet production and thrombotic complications. The inhibition of platelet cyclooxygenase (COX) activity by the standard once‐daily aspirin is mostly incomplete due to accelerated thrombopoiesis. The phase II...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tosetto, Alberto, Rocca, Bianca, Petrucci, Giovanna, Betti, Silvia, Soldati, Denise, Rossi, Elena, Timillero, Andrea, Cavalca, Viviana, Porro, Benedetta, Iurlo, Alessandra, Cattaneo, Daniele, Bucelli, Cristina, Dragani, Alfredo, Di Ianni, Mauro, Ranalli, Paola, Palandri, Francesca, Vianelli, Nicola, Beggiato, Eloise, Lanzarone, Giuseppe, Ruggeri, Marco, Carli, Giuseppe, Elli, Elena Maria, Priolo, Stefania, Randi, Maria Luigia, Bertozzi, Irene, Loscocco, Giuseppe Gaetano, Ricco, Alessandra, Specchia, Giorgina, Vannucchi, Alessandro Maria, Rodeghiero, Francesco, De Stefano, Valerio, Patrono, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299058/ https://www.ncbi.nlm.nih.gov/pubmed/34743317 http://dx.doi.org/10.1002/cpt.2485

Ejemplares similares

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
por: De Stefano, Valerio, et al.
Publicado: (2018)

Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation
por: Petrucci, Giovanna, et al.
Publicado: (2022)

Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis
por: Cattaneo, Daniele, et al.
Publicado: (2022)

Thromboxane generation by human monocytes enhances platelet function
Publicado: (1986)

Platelet Dysfunction in Type 1 Diabetes: Stressing the Thromboxanes
por: Wisinski, Jaclyn A., et al.
Publicado: (2016)

Measurement of Thromboxane Biosynthesis in Health and Disease
por: Patrono, Carlo, et al.
Publicado: (2019)

Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane
Publicado: (1991)

Effects of Aspirin and Prednisone on Platelet Function and Thromboxane Synthesis in Healthy Dogs
por: Thomason, John M., et al.
Publicado: (2019)

Can pegylated interferon improve the outcome of polycythemia vera patients?
por: Crisà, Elena, et al.
Publicado: (2017)

Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance
por: Breccia, Massimo, et al.
Publicado: (2022)

Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets
por: Raz, Limor, et al.
Publicado: (2014)

P1041: LEUKOCYTOSIS SELECTS A SUBGROUP OF LOW-RISK PV PATIENTS IN WHOM PHLEBOTOMY-ALONE MAY BE INSUFFICIENT
por: Carobbio, Alessandra, et al.
Publicado: (2023)

Fifty years with aspirin and platelets
por: Patrono, Carlo
Publicado: (2022)

Human Thromboxane A(2) Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis
por: Gleim, Scott, et al.
Publicado: (2013)

Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project
por: Raparelli, V., et al.
Publicado: (2022)

Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation
por: Cahill, Katherine N., et al.
Publicado: (2022)

Management of polycythemia vera: A survey of treatment patterns in Italy
por: Palumbo, Giuseppe Alberto, et al.
Publicado: (2022)

Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs
por: Minuz, Pietro, et al.
Publicado: (2018)

Correction: Human Thromboxane A(2) Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis
por: Gleim, Scott, et al.
Publicado: (2013)

Phosphorylation of protein kinase Cδ Tyr311 positively regulates thromboxane generation in platelets
por: Kostyak, John C., et al.
Publicado: (2021)

Canine platelets express functional Toll-like receptor-4: lipopolysaccharide-triggered platelet activation is dependent on adenosine diphosphate and thromboxane A2 in dogs
por: Li, Ronald H. L., et al.
Publicado: (2019)

New Perspectives on Polycythemia Vera: From Diagnosis to Therapy
por: Iurlo, Alessandra, et al.
Publicado: (2020)

Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge
por: Iurlo, Alessandra, et al.
Publicado: (2021)

Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A(2)
por: Lucotti, Serena, et al.
Publicado: (2019)

Derrone Inhibits Platelet Aggregation, Granule Secretion, Thromboxane A(2) Generation, and Clot Retraction: An In Vitro Study
por: Shin, Jung-Hae, et al.
Publicado: (2021)

Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future
por: Astori, Giuseppe, et al.
Publicado: (2016)

Platelets: "multiple choice" effectors in the immune response and their implication in COVID‐19 thromboinflammatory process
por: Rolla, Roberta, et al.
Publicado: (2021)

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms
por: De Stefano, Valerio, et al.
Publicado: (2018)

G(12/13) Signaling Pathways Substitute for Integrin αIIbβ3-Signaling for Thromboxane Generation in Platelets
por: Bhavaraju, Kamala, et al.
Publicado: (2011)

Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss †
por: Simeone, Paola, et al.
Publicado: (2018)

Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
por: Cattaneo, Daniele, et al.
Publicado: (2021)

P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MONOTHERAPY: PREDICTORS OF EARLY DISCONTINUATION AND DEATH ON TREATMENT. THE SHORT-TERM RUX PROGNOSTIC MODEL (STR-PM)
por: Palandri, Francesca, et al.
Publicado: (2023)

Total Saponin from Korean Red Ginseng Inhibits Thromboxane A(2) Production Associated Microsomal Enzyme Activity in Platelets
por: Lee, Dong-Ha, et al.
Publicado: (2012)

Daidzein Inhibits Human Platelet Activation by Downregulating Thromboxane A(2) Production and Granule Release, Regardless of COX-1 Activity
por: Hong, Hyun-Jin, et al.
Publicado: (2023)

Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway
por: Bury, Loredana, et al.
Publicado: (2021)

The role of platelets in the pathogenesis of systemic sclerosis
por: Ramirez, Giuseppe A., et al.
Publicado: (2012)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
por: Casonato, Alessandra, et al.
Publicado: (2016)

Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients
por: Cutica, Ilaria, et al.
Publicado: (2022)

Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro
por: Mariani, Erminia, et al.
Publicado: (2015)

Protein disulfide isomerase‐A1 regulates intraplatelet reactive oxygen species–thromboxane A(2)‐dependent pathway in human platelets
por: Przyborowski, Kamil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_itma43paub7a7mjgi0b6pgrhsg